Development of light-responsive protein binding in the monobody non-immunoglobulin scaffold
The ability to reversibly control monobody binding affinity would find use in biotechnology and research applications. Here the authors fuse the light-sensitive AsLOV2 domain to a monobody against the Abl SH2 domain to obtain a light dependent monobody and apply it in vitro and in mammalian cells.
Guardado en:
Autores principales: | César Carrasco-López, Evan M. Zhao, Agnieszka A. Gil, Nathan Alam, Jared E. Toettcher, José L. Avalos |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a5b4af23cb0e4709b1e40c0939dbc35a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Optogenetic control of protein binding using light-switchable nanobodies
por: Agnieszka A. Gil, et al.
Publicado: (2020) -
Tuning SAS-6 architecture with monobodies impairs distinct steps of centriole assembly
por: Georgios N. Hatzopoulos, et al.
Publicado: (2021) -
Selective inhibition of STAT3 signaling using monobodies targeting the coiled-coil and N-terminal domains
por: Grégory La Sala, et al.
Publicado: (2020) -
Scaffolding proteins guide the evolution of algal light harvesting antennas
por: Harry W. Rathbone, et al.
Publicado: (2021) -
THE INDIVIDUAL DIFFERENCE OF ABILITY BINDING BRAIN TUMOR CELLS WITH IMMUNOGLOBULIN G
por: O. V. Ostreiko, et al.
Publicado: (2014)